The $2 Trillion Valuation Debate Skips What Anthropic Knows 
Pharmacore secures funding to improve medication regimen reviews in long-term care Zuora Introduces the Command Center, Available for All Zuora Customers
One place for Zuora Admins to monitor critical activity and troubleshoot problems across multiple environments,…
CapturePoint Solutions Co-Sponsors Vernon Parish School Board Initiative to Create Career Training and Job Opportunities for Local High School Students
United Association also co-sponsors initiative, which will provide funding and services to update a dedicated…
Evertz Technologies Reports Record Quarterly Revenue of $129 Million, Record Annual Revenue of $455 Million for Periods Ending April 30, 2023 and Record Backlog of $392 Million
Burlington, Ontario–(Newsfile Corp. – June 21, 2023) – Evertz Technologies Limited (TSX: ET), the leader…
Federal Area Median Income Limit Adjustment: More California Homeowners Eligible for COVID-19 Relief Grant of up to $80,000
Annual adjustment to income rates leads to increases in the 150% AMI rate for California…
Codenotary Launches Fully Managed Immutable Cloud Database
Immudb Vault provides cryptographic integrity verification for business-to-business secure data sharing HOUSTON–(BUSINESS WIRE)–#codenotary—immudb, the only…
Great Point Partners Exits Vālenz® Health After 6-Year Partnership
Valenz enters next chapter of growth with strong financial foundation from GPP GREENWICH, Conn.–(BUSINESS WIRE)–Great…
Espressive Wins ‘Best Overall Bot Solution’ Designation in 2023 Artificial Intelligence Breakthrough Awards Program
Prestigious International Annual Awards Program Honors Espressive Barista as Standout AI Solution for Enhancing Employee…
CloudBees Announces DevOps World 2023
DevOps World to inspire growth and innovation through five events with sessions from industry experts….
Accenture to Acquire Anser Advisory to Expand Capital Project Capabilities
Accenture will help clients more efficiently deliver large infrastructure projects in North America NEW YORK…
IGM Announces Proposed Public Offering and Concurrent Private Placement
MOUNTAIN VIEW, Calif., June 21, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (NASDAQ: IGMS) today…
Roivant to Host Investor Call at 8:00 AM ET on Thursday, June 22 to Review Results from the Chronic Period of TUSCANY-2, a Large Global Phase 2b Study of RVT-3101 (Anti-TL1A Antibody) in Ulcerative Colitis
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) —…
Vaxart Encourages All Stockholders of Record as of April 28, 2023 to Vote by June 25, 2023, at 11:59 p.m. ET
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today encourages…
Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating…
Bon Natural Life Limited Receives NASDAQ Notification Regarding Minimum Bid Deficiency
XI’AN, China, June 21, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Panbela Announces Closing of Approximately $8.5 Million Public Offering
MINNEAPOLIS, June 21, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive…
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
— Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both…
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
PORTLAND, Maine, June 21, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Larimar Therapeutics Set to Join Russell 3000® Index
BALA CYNWYD, Pa., June 21, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
Personas Announces Correction to Press Release Announcing Closing of $1.15 Million Non-Brokered Private Placement
Correcting and Replacing“Warrants, the closing price of the Company’s Common Shares on the TSX Venture…